These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 11338915)

  • 1. Co-morbidity of 'clinical trial' versus 'real-world' patients using cardiovascular drugs.
    Wieringa NF; Vos R; van der Werf GT; van der Veen WJ; de Graeff PA
    Pharmacoepidemiol Drug Saf; 2000 Dec; 9(7):569-79. PubMed ID: 11338915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular drugs: discrepancies in demographics between pre- and post-registration use.
    Wieringa NF; de Graeff PA; van der Werf GT; Vos R
    Eur J Clin Pharmacol; 1999 Sep; 55(7):537-44. PubMed ID: 10501825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patients with chronic heart failure encountered in daily clinical practice are different from the "typical" patient enrolled in therapeutic trials.
    Badano LP; Di Lenarda A; Bellotti P; Albanese MC; Sinagra G; Fioretti PM
    Ital Heart J; 2003 Feb; 4(2):84-91. PubMed ID: 12762270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.
    Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ;
    Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):e149-61. PubMed ID: 15297292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines.
    Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ;
    J Am Coll Cardiol; 2004 Aug; 44(3):720-32. PubMed ID: 15358046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prevalence of cardiovascular disease risk factors in patients from Croatian Zagorje County treated at Department of Medicine, Zabok General Hospital from 2000 to 2006.
    Pesek K; Pesek T; Rados M; Buković D; Fures R; Cuk V
    Coll Antropol; 2007 Sep; 31(3):709-15. PubMed ID: 18041378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cardiovascular risk in hemodialysis in Spain: prevalence, management and target results (MAR study)].
    Portolés J; López-Gómez JM; Aljama P
    Nefrologia; 2005; 25(3):297-306. PubMed ID: 16053011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood pressure control and drug therapy in patients with diagnosed hypertension: a survey in Italian general practice.
    Filippi A; Paolini I; Innocenti F; Mazzaglia G; Battaggia A; Brignoli O
    J Hum Hypertens; 2009 Nov; 23(11):758-63. PubMed ID: 19242492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Controlled randomized clinical trials].
    Jaillon P
    Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The SaM (Screening and Monitoring) approach to cardiovascular risk-reduction in primary care--cyclic monitoring and individual treatment of patients at cardiovascular risk using the electronic medical record.
    Rabinowitz I; Tamir A
    Eur J Cardiovasc Prev Rehabil; 2005 Feb; 12(1):56-62. PubMed ID: 15703507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Use of rofecoxib in family practice in the north of Netherlands, 2000-2004: background and consequences].
    van der Veen WJ; van der Werf GT
    Ned Tijdschr Geneeskd; 2006 May; 150(18):1016-21. PubMed ID: 16715866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of patients with suspected angina, but without known myocardial infarction: a cross-sectional survey.
    Filippi A; Gensini G; Bignanimi AA; Sabatini A; Mazzaglia G; Cricelli C
    Br J Gen Pract; 2004 Jun; 54(503):429-33. PubMed ID: 15186563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute coronary care in the elderly, part II: ST-segment-elevation myocardial infarction: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology.
    Alexander KP; Newby LK; Armstrong PW; Cannon CP; Gibler WB; Rich MW; Van de Werf F; White HD; Weaver WD; Naylor MD; Gore JM; Krumholz HM; Ohman EM; ;
    Circulation; 2007 May; 115(19):2570-89. PubMed ID: 17502591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The benefit of cholesterol-lowering medications after coronary revascularization: a population study.
    Brophy JM; Brassard P; Bourgault C
    Am Heart J; 2005 Aug; 150(2):282-6. PubMed ID: 16086931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical data gap between phase III clinical trials (pre-marketing) and phase IV (post-marketing) studies: evaluation of etanercept in rheumatoid arthritis.
    Farahani P; Levine M; Gaebel K; Thabane L
    Can J Clin Pharmacol; 2005; 12(3):e254-63. PubMed ID: 16278497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hypercholesterolemia as cardiovascular risk in hypertensive patients. Therapeutic implications: efficiency of statins].
    Borghi C; Veronesi M
    Recenti Prog Med; 2003 Oct; 94(10):421-6. PubMed ID: 14619187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ACTION study: nifedipine in patients with symptomatic stable angina and hypertension.
    Sierra C; Coca A
    Expert Rev Cardiovasc Ther; 2008 Sep; 6(8):1055-62. PubMed ID: 18793108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging therapies for angina: new modalities may offer additional clinical options.
    Schroeder JS
    Manag Care Interface; 2004 Apr; 17(4):45-52. PubMed ID: 15108760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age, comorbidity and hypertensive co-medication do not affect cardiovascular tolerability of 10 mg alfuzosin once daily.
    Hartung R; Matzkin H; Alcaraz A; Emberton M; Harving N; van Moorselaar J; Elhilali M; Vallancien G;
    J Urol; 2006 Feb; 175(2):624-8; discussion 628. PubMed ID: 16407011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term outcome in elderly patients with chronic angina managed invasively versus by optimized medical therapy: four-year follow-up of the randomized Trial of Invasive versus Medical therapy in Elderly patients (TIME).
    Pfisterer M;
    Circulation; 2004 Sep; 110(10):1213-8. PubMed ID: 15337691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.